Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;196(9):749-763.
doi: 10.1007/s00066-020-01613-z. Epub 2020 Apr 29.

DEGRO practical guideline for partial-breast irradiation

V Strnad  1 , D Krug  2 , F Sedlmayer  3 , M D Piroth  4 , W Budach  5 , R Baumann  6 , P Feyer  7 , M N Duma  8 , W Haase  9 , W Harms  10 , T Hehr  11 , R Fietkau  12 , J Dunst  2 , R Sauer  12 ; Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO)
Affiliations
Review

DEGRO practical guideline for partial-breast irradiation

V Strnad et al. Strahlenther Onkol. 2020 Sep.

Abstract

Purpose: This consensus statement from the Breast Cancer Working Group of the German Society for Radiation Oncology (DEGRO) aims to define practical guidelines for accelerated partial-breast irradiation (APBI).

Methods: Recent recommendations for relevant aspects of APBI were summarized and a panel of experts reviewed all the relevant literature. Panel members of the DEGRO experts participated in a series of conferences, supplemented their clinical experience, performed a literature review, and formulated recommendations for implementing APBI in clinical routine, focusing on patient selection, target definition, and treatment technique.

Results: Appropriate patient selection, target definition for different APBI techniques, and basic rules for appropriate APBI techniques for clinical routine outside of clinical trials are described. Detailed recommendations for APBI in daily practice, including dose constraints, are given.

Conclusion: Guidelines are mandatory to assure optimal results of APBI using different techniques.

Keywords: APBI; Breast cancer; Early breast cancer; Guideline; Partial breast irradiation.

PubMed Disclaimer

Conflict of interest statement

V. Strnad, D. Krug, F. Sedlmayer, M.D. Piroth, W. Budach, R. Baumann, P. Feyer, M.N. Duma, W. Haase, W. Harms, T. Hehr, R. Fietkau, J. Dunst, R. Sauer, and DEGRO declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Target delineation after closed-cavity surgery. WS whole scar (green), ImTV imaging-correlated target volume (dark blue), ETB estimated tumor bed (yellow), CTV clinical target volume (orange), PTV(Brachy) planning target volume for brachytherapy (dark-red), PTV(EBRT) planning target volume for external beam radiation therapy (light red), PTVEVAL planning target volume for evaluation (light-blue)
See this image and copyright information in PMC

References

    1. Strnad V, Ott OJ, Hildebrandt G, et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet. 2016;387(10015):229–238. - PubMed
    1. Coles CE, Griffin CL, Kirby AM, et al. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet. 2017;390(10099):1048–1060. - PMC - PubMed
    1. Polgar C, Ott OJ, Hildebrandt G, et al. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18(2):259–268. - PubMed
    1. Schafer R, Strnad V, Polgar C, et al. Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial. Lancet Oncol. 2018;19(6):834–844. - PubMed
    1. Livi L, Meattini I, Marrazzo L, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer. 2015;51(4):451–463. - PubMed

LinkOut - more resources